glaucoma |
brimonidine |
As nouns the difference between glaucoma and brimonidine
is that
glaucoma is (pathology) an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while
brimonidine is a drug used to treat open-angle glaucoma or ocular hypertension.
glaucoma |
acetazolamide |
As nouns the difference between glaucoma and acetazolamide
is that
glaucoma is (pathology) an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while
acetazolamide is a carbonic anhydrase inhibitor used to treat glaucoma and other conditions.
glaucoma |
betaxolol |
As nouns the difference between glaucoma and betaxolol
is that
glaucoma is (pathology) an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while
betaxolol is (medicine) a topical sympatholytic agent used to reduce ocular hypertension in the treatment of glaucoma.
glaucoma |
apraclonidine |
As nouns the difference between glaucoma and apraclonidine
is that
glaucoma is (pathology) an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while
apraclonidine is a sympathomimetic used in glaucoma therapy.
glaucoma |
bapineuzumab |
As nouns the difference between glaucoma and bapineuzumab
is that
glaucoma is (pathology) an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while
bapineuzumab is (pharmacy) a humanized monoclonal antibody that acts on the nervous system and has potential therapeutic value for the treatment of alzheimer's disease and possibly glaucoma.
Pages